64 Infos zu Leon Hooftman

21 Aktuelle Nachrichten

· Other Celltech old boys include Leon Hooftman, the chief medical officer, and David Moffat, head of chemistry. Chroma's directors include Peter ...

Markets may be in the doldrums, but every month, scientists and financiers meet over canapés in a London hospital to tap a funding bonanza. Nick...

Collie replaces Leighton at head of Lastminute.

DCPrime announced the appointments of Marcel Zwaal as Chief Executive Officer, and of Dr. Anthony Hall as Chief Medical Officer. Dr. Anthony Hall has 18 years...

5 Profile in Sozialen Netzwerken

Sehen Sie sich das Profil von Leon Hooftman auf LinkedIn an, dem weltweit größten beruflichen Netzwerk. Leon Hooftman hat 9 Jobs im Profil angegeben.

3 Hobbys & Interessen

Leading cancer vaccine company DCPrime appoints CEO, CMO and expands board; DCPrime develops off-the-shelf dendritic cell-based vaccines for a broad r

1 Firmen-Mitarbeiter

Currently, Chief Medical Officer at Polyphor AG, a biotechnology company leader in macrocycle drug development. … physician with more than

4 Dokumente

... Brian A. Walker,1 Emma L. Davenport,1 Lauren I. Aronson,1 David Krige,2 Leon Hooftman,2 Alan H. Drummond,2 Gareth J. Morgan,1 and Faith E. Davies1​ ...

Download Conference Agenda...

2 Wissenschaftliche Publikationen

One of the world's leading journals in the field of translational research, Journal of Translational Medicine is dedicated to turning fundamental...

· ... Achim Wach, Christophe Escot, Garry Douglas, Barbara Romagnoli, Eric Chevalier, Klaus Dembowski, Leon Hooftman, Halvard-Björn Bönig.

2 Allgemeine Veröffentlichungen

· ... Chevalier; , Klaus Dembowski; & Leon Hooftman. Institute for Transfusion Medicine and Immunohematology, Goethe University, Sandhofstr.

26 Webfunde aus dem Netz

She has been working in Europe, Asia and the Americas. Dr. Barker succeeds Leon Hooftman, MD, who leaves Polyphor to take a new position ...

Hoffmann-la Roche, Celltech Group Plc, Syntex or Synthon BV besides several others. In the last decade, Dr. Hooftman has completed more than 10 clinical Phase I ...

By Darja Karpova, Susanne Bräuninger, Eliza Wiercinska, et al., Published on

Ignace Vergote, MD, PhD. Jaap Oostendorp, PhD. Jan Wouter Drijfhout, PhD, Judith Kroep, MD, PhD. Leo de Waal, PhD. Leon Hooftman, MD, PhD. Linda Diehl ...

Experto clínico en Epigenética y en AML Dr. Leon Hooftman Celltech, Syntex o Synthon Profesor Harald Hampel Autoridad mundial en la enfermedad de ...

... Thierry Velu, Frederic Goffin, Roy Lalisang, Willem-Jan Krebber, Leon Hooftman, Sonja Visscher, Brent A. Blumenstein, Richard B. Stead, Winald Gerritsen

PhD,5*, Leon Hooftman, MD5 and Halvard Bonig, MD, MA1,3,6.

Dr. Leon Hooftman: Director Médico en Polyphor AG, Suiza en Roche, Celltech, Syntex o Synthon Profesor Harald Hampel: Autoridad mundial en la ... el FP7 europeo REPRO-TRAIN Reproductive Biology Early Research Training network, ...

Our expert advisors are available to assist our clients with general business and specific project needs.

... one of the most distinguished scientist entrepreneurs in the biotech industry, Dr​. Leon Hooftman who, following a high-profile career in clinical development, ...

Graduates of Universiteit Utrecht - the names, photos, skill, job, location. Information on the Universiteit Utrecht - contacts, students, faculty.

ImmunoGen, Inc. Message board - Online Community of active, educated investors researching and discussing ImmunoGen, Inc. Stocks.

Krug, Elisabeth Bone, Nicolas Flores, Alison F Richardson, Leon Hooftman, Chris  ...

· ... Willem Jan Krebber , Leon Hooftman , Sonja Visscher , Brent A Blumenstein , Richard B Stead , Winald Gerritsen , Sjoerd H van der Burg ...

Janine Oberyé1 , Evelyn van den Tweel , Marieke Mulder , Gerrit Voortman , Leon Hooftman. Author Affiliations. 1 Clinical Operations, Synthon BV, The ...